Medical device maker Emulate Therapeutics (EMTX) has set terms for a proposed IPO that would raise around $13M. Emulate said in a filing that it is looking to offer 2.5M shares priced between $4 and ...

Issuance of U.S. Design Patent No. D944,999 S advances EMulate Therapeutics' Intellectual Portfolio to 41 issued US and foreign patents. BELLEVUE, WA / ACCESSWIRE / March 7, 2022 / EMulate ...

EMulate Therapeutics, Inc. (EMTX) has filed proposed terms for a $12.5 million IPO of its common stock, according to an amended S-1/A registration statement. The company is developing medical device ...

BELLEVUE, Wash.--(BUSINESS WIRE)--EMulate Therapeutics, Inc. (EMulate) announced today the publication of its peer-reviewed clinical trial using EMulate’s technology for the treatment of glioblastoma ...

Feb. 9 (UPI) --A team from Binghamton University has created a reusable, multilayered and microfluidic device that emulates human kidney function. The device incorporates a porous growth substrate, ...

Issuance of U.S. Patent No. 11,103,721 B2 advances EMulate Therapeutics' Intellectual Portfolio to 38 issued US and foreign patents SEATTLE, WA / ACCESSWIRE / September 28, 2021 / EMulate Therapeutics ...